Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract

Journal of Autoimmunity

Volumn 34, Issue 3, 2010, Pages

  Powell, Jonathan J ^a   Faria, Nuno ^a   Thomas McKay, Emma ^a   Pele, Laetitia C ^a  

^a Elsie Widdowson Laboratory   (United Kingdom)

Author keywords

Gastrointestinal tract; Microparticles; Nanoparticles

Indexed keywords

ALUMINUM SILICATE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CRYOPYRIN; FERRITIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MURAMYL DIPEPTIDE; NANOPARTICLE; RAPESEED OIL; REACTIVE OXYGEN METABOLITE; TITANIUM DIOXIDE;

ARTICLE; CROHN DISEASE; CYTOKINE PRODUCTION; ENDOCYTOSIS; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRANSIT; GENOTYPE; HOST CELL; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; NANOBIOTECHNOLOGY; NANOENCAPSULATION; NANOENGINEERING; NANOTECHNOLOGY; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM;

ANIMALS; CROHN DISEASE; DIET; ENDOCYTOSIS; FOOD ADDITIVES; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; NANOPARTICLES; NANOTECHNOLOGY; NOD2 SIGNALING ADAPTOR PROTEIN; PARTICULATE MATTER; PEYER'S PATCHES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 77649185962     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.11.006     Document Type: Article

References (83)

1. Service R.F. Nanotechnology. Can high-speed tests sort out which nanomaterials are safe?. Science 321 5892 (2008) 1036-1037
2. The project on emerging Nano Technologies (2009). http://www.nanotechproject.org/news/archive/8277/
3. Luxresearch. Lux research. Overhyped technology starts to reach potential: nanotech to impact $3.1 trillion in manufactured goods in 2015. July 22; http://www.luxresearchinc.com/press/RELEASE_Nano-SMR_7_22_08.pdf; 2009.
4. Chaudhry Q., Scotter M., Blackburn J., Ross B., Boxall A., Castle L., et al. Applications and implications of nanotechnologies for the food sector. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25 3 (2008) 241-258
5. Nanoscience and nanotechnologies: opportunities and uncertainties (July 2004), The Royal Society & The Royal Academy of Engineering
6. Auffan M., Rose J., Bottero J.Y., Lowry G.V., Jolivet J.P., and Wiesner M.R. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nanotechnol 4 10 (2009) 634-641
7. Harding C.V., and Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol 153 11 (1994) 4925-4933
8. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8 7 (2009) 543-557
9. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9 8 (2008) 847-856
10. Gerloff K., Albrecht C., Boots A., Forster I., and Schins R. Cytotoxicity and oxidative DNA damage by nanoparticles in human intestinal Caco-2 cells. Nanotoxicology 3 4 (2009) 1-10
11. The project on emerging NanoTechnologies. http://www.nanotechproject.org/inventories/consumer/browse/companies/4686/ Accessed 2009
12. BBC. Nanofoods (2009). www.bbc.co.uk/radio4/science/frontiers_20081020.shtml
13. Powell J.J., Thoree V., and Pele L.C. Dietary microparticles and their impact on tolerance and immune responsiveness of the gastrointestinal tract. Br J Nutr 98 Suppl. 1 (2007) S59-S63
14. Powell J.J., Ainley C.C., Harvey R.S., Mason I.M., Kendall M.D., Sankey E.A., et al. Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut 38 3 (1996) 390-395
15. Thoree V., Skepper J., Deere H., Pele L.C., Thompson R.P., and Powell J.J. Phenotype of exogenous microparticle-containing pigment cells of the human Peyer's patch in inflamed and normal ileum. Inflamm Res 57 8 (2008) 374-378
16. Evans S.M., Ashwood P., Warley A., Berisha F., Thompson R.P., and Powell J.J. The role of dietary microparticles and calcium in apoptosis and interleukin-1beta release of intestinal macrophages. Gastroenterology 123 5 (2002) 1543-1553
17. Stone V., Johnston H., and Schins R.P. Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol 39 7 (2009) 613-626
18. Dobrovolskaia M.A., Germolec D.R., and Weaver J.L. Evaluation of nanoparticle immunotoxicity. Nat Nanotechnol 4 7 (2009) 411-414
19. Bihari P., Vippola M., Schultes S., Praetner M., Khandoga A.G., Reichel C.A., et al. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol 5 (2008) 14
20. 2 nanoparticles in cell culture medium. Colloids Surf B Biointerfaces 68 1 (2009) 83-87
21. Nichols G., Byard S., Bloxham M.J., Botterill J., Dawson N.J., Dennis A., et al. A review of the terms agglomerate and aggregate with a recommendation for nomenclature used in powder and particle characterization. J Pharm Sci 91 10 (2002) 2103-2109
22. Institute BS. Terminology for nanoparticles, PAS 136 (2007), BSI, London
23. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., and Dawson K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105 38 (2008) 14265-14270
24. Powell J.J., Harvey R.S., Ashwood P., Wolstencroft R., Gershwin M.E., and Thompson R.P. Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J Autoimmun 14 1 (2000) 99-105
25. Ashwood P., Thompson R.P., and Powell J.J. Fine particles that adsorb lipopolysaccharide via bridging calcium cations may mimic bacterial pathogenicity towards cells. Exp Biol Med (Maywood) 232 1 (2007) 107-117
26. Jugdaohsingh R., O'Connell M.A., Sripanyakorn S., and Powell J.J. Moderate alcohol consumption and increased bone mineral density: potential ethanol and non-ethanol mechanisms. Proc Nutr Soc 65 3 (2006) 291-310
27. Powell J.J., Ainley C.C., Evans R., and Thompson R.P. Intestinal perfusion of dietary levels of aluminium: association with the mucosa. Gut 35 8 (1994) 1053-1057
28. Moller W., Felten K., Meyer G., Meyer P., Seitz J., and Kreyling W.G. Corrections in dose assessment of 99mTc radiolabeled aerosol particles targeted to central human airways using planar gamma camera imaging. J Aerosol Med Pulm Drug Deliv 22 1 (2009) 45-54
29. Jani P.U., Nomura T., Yamashita F., Takakura Y., Florence A.T., and Hashida M. Biliary excretion of polystyrene microspheres with covalently linked FITC fluorescence after oral and parenteral administration to male Wistar rats. J Drug Target 4 2 (1996) 87-93
30. Cho M., Cho W.S., Choi M., Kim S.J., Han B.S., Kim S.H., et al. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 189 3 (2009) 177-183
31. Powell J.J., Evans S.M., Lomer M.C., and Thompson R.P.H. What are intestinal pigment cells?. Inflamm Bowel Dis Mon 1 3 (1999) 71-74
32. Hillery A.M., Jani P.U., and Florence A.T. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. J Drug Target 2 2 (1994) 151-156
33. McClean S., Prosser E., Meehan E., O'Malley D., Clarke N., Ramtoola Z., et al. Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia. Eur J Pharm Sci 6 2 (1998) 153-163
34. Moyes S.M., Smyth S.H., Shipman A., Long S., Morris J.F., and Carr K.E. Parameters influencing intestinal epithelial permeability and microparticle uptake in vitro. Int J Pharm 337 1-2 (2007) 133-141
35. Gaumet M., Gurny R., and Delie F. Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size. Eur J Pharm Sci 36 4-5 (2009) 465-473
36. Cartiera M.S., Johnson K.M., Rajendran V., Caplan M.J., and Saltzman W.M. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials 30 14 (2009) 2790-2798
37. Smythies L.E., Sellers M., Clements R.H., Mosteller-Barnum M., Meng G., Benjamin W.H., et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115 1 (2005) 66-75
38. Pan Y.H., Sader K., Powell J.J., Bleloch A., Gass M., Trinick J., et al. 3D morphology of the human hepatic ferritin mineral core: new evidence for a subunit structure revealed by single particle analysis of HAADF-STEM images. J Struct Biol 166 1 (2009) 22-31
39. Kalgaonkar S., and Lonnerdal B. Receptor-mediated uptake of ferritin-bound iron by human intestinal Caco-2 cells. J Nutr Biochem 20 4 (2009) 304-311
40. Lomer M.C., Thompson R.P., and Powell J.J. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc 61 1 (2002) 123-130
41. Pele L.C., and Powell J.J. Microparticles: a link between modern life and inflammatory bowel disease?. In: Colombel J.F., Gasche C., Scholmerich J., and Vucelic B. (Eds). IBD: translation from basic research to clinical practice (2004), Kluwer Academic Publishers 123-137
42. Lomer M.C., Hutchinson C., Volkert S., Greenfield S.M., Catterall A., Thompson R.P., et al. Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn's disease. Br J Nutr 92 6 (2004) 947-955
43. des Rieux A., Ragnarsson E.G., Gullberg E., Preat V., Schneider Y.J., and Artursson P. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur J Pharm Sci 25 4-5 (2005) 455-465
44. Seifert J., and Sass W. Intestinal absorption of macromolecules and small particles. Dig Dis 8 3 (1990) 169-178
45. Sass W., Dreyer H.P., and Seifert J. Rapid insorption of small particles in the gut. Am J Gastroenterol 85 3 (1990) 255-260
46. Seifert J., Haraszti B., and Sass W. The influence of age and particle number on absorption of polystyrene particles from the rat gut. J Anat 189 Pt 3 (1996) 483-486
47. Gebert A., Rothkotter H.J., and Pabst R. M cells in Peyer's patches of the intestine. Int Rev Cytol 167 (1996) 91-159
48. Beier R., and Gebert A. Kinetics of particle uptake in the domes of Peyer's patches. Am J Physiol 275 1 Pt 1 (1998) G130-G137
49. Bockmann J., Lahl H., Eckert T., and Unterhalt B. Blood titanium levels before and after oral administration titanium dioxide. Pharmazie 55 2 (2000) 140-143
50. Volkheimer G. Passage of particles through the wall of the gastrointestinal tract. Environ Health Perspect 9 (1974) 215-225
51. Volkheimer G. Persorption of microparticles. Pathologe 14 5 (1993) 247-252
52. Hillyer J.F., and Albrecht R.M. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 90 12 (2001) 1927-1936
53. Jepson M.A., Simmons N.L., Savidge T.C., James P.S., and Hirst B.H. Selective binding and transcytosis of latex microspheres by rabbit intestinal M cells. Cell Tissue Res 271 3 (1993) 399-405
54. Hussain N., Jaitley V., and Florence A.T. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev 50 1-2 (2001) 107-142
55. Freedman B.J. Persorption of raw starch: a cause of senile dementia?. Med Hypotheses 35 2 (1991) 85-87
56. Powell J.J., Whitehead M.W., Lee S., and Thompson R.P.H. Mechanisms of gastrointestinal absorption: dietary minerals and the influence of beverage ingestion. Food Chem 51 (1994) 381-388
57. Hussain N., Jani P.U., and Florence A.T. Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat. Pharm Res 14 5 (1997) 613-618
58. Jani P., Halbert G.W., Langridge J., and Florence A.T. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol 42 12 (1990) 821-826
59. Smyth S.H., Feldhaus S., Schumacher U., and Carr K.E. Uptake of inert microparticles in normal and immune deficient mice. Int J Pharm 346 1-2 (2008) 109-118
60. Doyle-McCullough M., Smyth S.H., Moyes S.M., and Carr K.E. Factors influencing intestinal microparticle uptake in vivo. Int J Pharm 335 1-2 (2007) 79-89
61. Xia T., Li N., and Nel A.E. Potential health impact of nanoparticles. Annu Rev Public Health 30 (2009) 137-150
62. Kovacsovics-Bankowski M., Clark K., Benacerraf B., and Rock K.L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci USA 90 11 (1993) 4942-4946
63. Pele L.C., Thompson S.J., Kirkham B., Thompson R.P., and Powell J.J. Peripheral blood mononuclear cell proliferative responses to soluble and particulate heat shock protein 65 in health and inflammatory bowel disease. Inflamm Res 56 4 (2007) 143-148
64. Song R., and Harding C.V. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J Immunol 156 11 (1996) 4182-4190
65. Shen H., Ackerman A.L., Cody V., Giodini A., Hinson E.R., Cresswell P., et al. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 117 1 (2006) 78-88
66. Singh M., Chakrapani A., and O'Hagan D. Nanoparticles and microparticles as vaccine-delivery systems. Expert Rev Vaccines 6 5 (2007) 797-808
67. Butler M., Boyle J.J., Powell J.J., Playford R.J., and Ghosh S. Dietary microparticles implicated in Crohn's disease can impair macrophage phagocytic activity and act as adjuvants in the presence of bacterial stimuli. Inflamm Res 56 9 (2007) 353-361
68. Evans S.M., Powell J.J., Ashwood P., Thompson R.P.H., and Harvey R.S. Ultrafine particles in the Aetiology of Crohn's disease. Inflamm Bowel Dis Mon 1 2 (1999) 39-45
69. Johnson C.J., Pedersen J.A., Chappell R.J., McKenzie D., and Aiken J.M. Oral transmissibility of prion disease is enhanced by binding to soil particles. PLoS Pathog 3 7 (2007) e93
70. Johnson C.J., Phillips K.E., Schramm P.T., McKenzie D., Aiken J.M., and Pedersen J.A. Prions adhere to soil minerals and remain infectious. PLoS Pathog 2 4 (2006) e32
71. Bonen D.K., Ogura Y., Nicolae D.L., Inohara N., Saab L., Tanabe T., et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124 1 (2003) 140-146
72. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278 11 (2003) 8869-8872
73. Cuthbert A.P., Fisher S.A., Mirza M.M., King K., Hampe J., Croucher P.J., et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122 4 (2002) 867-874
74. Ahmad T., Armuzzi A., Bunce M., Mulcahy-Hawes K., Marshall S.E., Orchard T.R., et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 122 4 (2002) 854-866
75. Barreau F., Meinzer U., Chareyre F., Berrebi D., Niwa-Kawakita M., Dussaillant M., et al. CARD15/NOD2 is required for Peyer's patches homeostasis in mice. PLoS One 2 (2007) e523
76. Rioux J.D., Xavier R.J., Taylor K.D., Silverberg M.S., Goyette P., Huett A., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39 5 (2007) 596-604
77. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39 2 (2007) 207-211
78. Xavier R.J., Huett A., and Rioux J.D. Autophagy as an important process in gut homeostasis and Crohn's disease pathogenesis. Gut 57 6 (2008) 717-720
79. Kuballa P., Huett A., Rioux J.D., Daly M.J., and Xavier R.J. Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLoS One 3 10 (2008) e3391
80. Levine B., and Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 7 10 (2007) 767-777
81. Nedjic J., Aichinger M., Emmerich J., Mizushima N., and Klein L. Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 455 7211 (2008) 396-400
82. Nedjic J., Aichinger M., and Klein L. A novel role for autophagy in T cell education. Autophagy 4 8 (2008) 1090-1092
83. Zabirnyk O., Yezhelyev M., and Seleverstov O. Nanoparticles as a novel class of autophagy activators. Autophagy 3 3 (2007) 278-281